Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $619.3200 (1.29%) ($619.3200 - $624.6300) on Fri. Mar. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.61% (three month average) | RSI | 40 | Latest Price | $619.3200(1.29%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -1.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(41%) XLV(40%) IWD(39%) IVE(37%) | Factors Impacting REGN price | REGN will decline at least -0.805% in a week (0% probabilities). VIXM(-20%) TBT(-10%) UUP(-8%) VXX(-3%) USO(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.805% (StdDev 1.61%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $614.81(0.73%) | 10 Day Moving Average | $613.14(1.01%) | 20 Day Moving Average | $618.65(0.11%) | To recent high | -7.7% | To recent low | 4.1% | Market Cap | $65.666b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |